Literature DB >> 30463913

HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genes.

Xiaoxia Zhong1, Andreas Prinz1, Julia Steger1, Maria-Paz Garcia-Cuellar1, Markus Radsak2, Abderrazzak Bentaher3, Robert K Slany1.   

Abstract

Ectopic expression of the oncogenic transcription factor HoxA9 is a major cause of acute myeloid leukemia (AML). Here, we demonstrate that HoxA9 is a specific substrate of granule proteases. Protease knockout allowed the comprehensive determination of genome-wide HoxA9 binding sites by chromatin immunoprecipitation sequencing in primary murine cells and a human AML cell line. The kinetics of enhancer activity and transcription rates in response to alterations of an inducible HoxA9 were determined. This permitted identification of HoxA9-controlled enhancers and promoters, allocation to their respective transcription units, and discrimination against HoxA9-bound, but unresponsive, elements. HoxA9 triggered an elaborate positive-feedback loop that drove expression of the complete Hox-A locus. In addition, it controlled key oncogenic transcription factors Myc and Myb and directly induced the cell cycle regulators Cdk6 and CyclinD1, as well as telomerase, drawing the essential blueprint for perturbation of proliferation by leukemogenic HoxA9 expression.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30463913      PMCID: PMC6258913          DOI: 10.1182/bloodadvances.2018025866

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  38 in total

1.  The homeodomain region controls the phenotype of HOX-induced murine leukemia.

Authors:  Constanze Breitinger; Emanuel Maethner; Maria-Paz Garcia-Cuellar; Robert K Slany
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

2.  Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes.

Authors:  Maria-Paz Garcia-Cuellar; Christian Büttner; Christoph Bartenhagen; Martin Dugas; Robert K Slany
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

3.  Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema.

Authors:  Nicolas Guyot; Julien Wartelle; Laurette Malleret; Alexandre A Todorov; Gilles Devouassoux; Yves Pacheco; Dieter E Jenne; Azzaq Belaaouaj
Journal:  Am J Pathol       Date:  2014-06-12       Impact factor: 4.307

4.  Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.

Authors:  U Thorsteinsdottir; E Kroon; L Jerome; F Blasi; G Sauvageau
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

5.  HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.

Authors:  Yuqing Sun; Bo Zhou; Fengbiao Mao; Jing Xu; Hongzhi Miao; Zhenhua Zou; Le Tran Phuc Khoa; Younghoon Jang; Sheng Cai; Matthew Witkin; Richard Koche; Kai Ge; Gregory R Dressler; Ross L Levine; Scott A Armstrong; Yali Dou; Jay L Hess
Journal:  Cancer Cell       Date:  2018-09-27       Impact factor: 31.743

6.  HOXA9 regulates miR-155 in hematopoietic cells.

Authors:  Yu-Long Hu; Stephen Fong; Corey Largman; Wei-Fang Shen
Journal:  Nucleic Acids Res       Date:  2010-05-05       Impact factor: 16.971

7.  PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.

Authors:  Zejuan Li; Ping Chen; Rui Su; Chao Hu; Yuanyuan Li; Abdel G Elkahloun; Zhixiang Zuo; Sandeep Gurbuxani; Stephen Arnovitz; Hengyou Weng; Yungui Wang; Shenglai Li; Hao Huang; Mary Beth Neilly; Gang Greg Wang; Xi Jiang; Paul P Liu; Jie Jin; Jianjun Chen
Journal:  Cancer Res       Date:  2016-01-08       Impact factor: 12.701

8.  The functional consequences of variation in transcription factor binding.

Authors:  Darren A Cusanovich; Bryan Pavlovic; Jonathan K Pritchard; Yoav Gilad
Journal:  PLoS Genet       Date:  2014-03-06       Impact factor: 5.917

9.  Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.

Authors:  Dirk Heckl; Monika S Kowalczyk; David Yudovich; Roger Belizaire; Rishi V Puram; Marie E McConkey; Anne Thielke; Jon C Aster; Aviv Regev; Benjamin L Ebert
Journal:  Nat Biotechnol       Date:  2014-06-22       Impact factor: 54.908

10.  The long-range interaction landscape of gene promoters.

Authors:  Amartya Sanyal; Bryan R Lajoie; Gaurav Jain; Job Dekker
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

View more
  13 in total

1.  Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML.

Authors:  Molly C Kingsley; Hongbo M Xie; Bo-Rui Chen; Simone S Riedel; Taylor Pastuer; Madelyn K Bollig; Tyler Shank; Clara Libbrecht; Sally P Stabler; Aniruddha J Deshpande; Andrew M Intlekofer; Kathrin M Bernt
Journal:  Blood Adv       Date:  2020-07-14

2.  CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.

Authors:  Johannes Schmoellerl; Inês Amorim Monteiro Barbosa; Thomas Eder; Tania Brandstoetter; Luisa Schmidt; Barbara Maurer; Selina Troester; Ha Thi Thanh Pham; Mohanty Sagarajit; Jessica Ebner; Gabriele Manhart; Ezgi Aslan; Stefan Terlecki-Zaniewicz; Christa Van der Veen; Gregor Hoermann; Nicolas Duployez; Arnaud Petit; Helene Lapillonne; Alexandre Puissant; Raphael Itzykson; Richard Moriggl; Michael Heuser; Roland Meisel; Peter Valent; Veronika Sexl; Johannes Zuber; Florian Grebien
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 3.  Multiple roles of HOX proteins in Metastasis: Let me count the ways.

Authors:  Joy Jonkers; Priya Pai; Saraswati Sukumar
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  Identification of RIOK2 as a master regulator of human blood cell development.

Authors:  Shrestha Ghosh; Mahesh Raundhal; Samuel A Myers; Steven A Carr; Xi Chen; Gregory A Petsko; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2021-12-22       Impact factor: 25.606

5.  HOXA9 has the hallmarks of a biological switch with implications in blood cancers.

Authors:  Laure Talarmain; Matthew A Clarke; David Shorthouse; Lilia Cabrera-Cosme; David G Kent; Jasmin Fisher; Benjamin A Hall
Journal:  Nat Commun       Date:  2022-10-03       Impact factor: 17.694

6.  Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.

Authors:  Simone S Riedel; Congcong Lu; Hongbo M Xie; Kevin Nestler; Marit W Vermunt; Alexandra Lenard; Laura Bennett; Nancy A Speck; Ichiro Hanamura; Julie A Lessard; Gerd A Blobel; Benjamin A Garcia; Kathrin M Bernt
Journal:  Mol Cell       Date:  2021-05-10       Impact factor: 19.328

7.  HoxA9 binds and represses the Cebpa +8 kb enhancer.

Authors:  Lei Peng; Hong Guo; Peilin Ma; Yuqing Sun; Lauren Dennison; Peter D Aplan; Jay L Hess; Alan D Friedman
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

8.  Overexpression of HOXA9 upregulates NF-κB signaling to promote human hematopoiesis and alter the hematopoietic differentiation potentials.

Authors:  Jiahui Zeng; Danying Yi; Wencui Sun; Yuanlin Liu; Jing Chang; Lijiao Zhu; Yonggang Zhang; Xu Pan; Yong Dong; Ya Zhou; Mowen Lai; Guohui Bian; Qiongxiu Zhou; Jiaxin Liu; Bo Chen; Feng Ma
Journal:  Cell Regen       Date:  2021-01-11

9.  Menin is necessary for long term maintenance of meningioma-1 driven leukemia.

Authors:  Clara Libbrecht; Hongbo M Xie; Molly C Kingsley; Jessica N Haladyna; Simone S Riedel; Fatemeh Alikarami; Alexandra Lenard; Gerard M McGeehan; Patricia Ernst; Kathrin M Bernt
Journal:  Leukemia       Date:  2021-02-04       Impact factor: 11.528

10.  Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.

Authors:  Ke Fang; Wei Huang; Yu-Meng Sun; Tian-Qi Chen; Zhan-Cheng Zeng; Qian-Qian Yang; Qi Pan; Cai Han; Lin-Yu Sun; Xue-Qun Luo; Wen-Tao Wang; Yue-Qin Chen
Journal:  Genome Biol       Date:  2020-11-03       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.